IT1293583B1 - Treating demential syndromes comprising administration of gammahydroxybutyric acid - Google Patents

Treating demential syndromes comprising administration of gammahydroxybutyric acid

Info

Publication number
IT1293583B1
IT1293583B1 IT97MI001613A ITMI971613A IT1293583B1 IT 1293583 B1 IT1293583 B1 IT 1293583B1 IT 97MI001613 A IT97MI001613 A IT 97MI001613A IT MI971613 A ITMI971613 A IT MI971613A IT 1293583 B1 IT1293583 B1 IT 1293583B1
Authority
IT
Italy
Prior art keywords
demential
treating
syndromes
administration
gammahydroxybutyric
Prior art date
Application number
IT97MI001613A
Other languages
Italian (it)
Inventor
Franco Beghe
Carlo Bertoni-Freddari
Patrizia Fattoretti
Maria Teresa Carpanini
Ugo Caselli
Roberta Paoloni
Original Assignee
Ct Lab Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Lab Farm Srl filed Critical Ct Lab Farm Srl
Priority to IT97MI001613A priority Critical patent/IT1293583B1/en
Publication of ITMI971613A0 publication Critical patent/ITMI971613A0/it
Priority to CA 2217902 priority patent/CA2217902A1/en
Publication of ITMI971613A1 publication Critical patent/ITMI971613A1/en
Application granted granted Critical
Publication of IT1293583B1 publication Critical patent/IT1293583B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The therapeutic method for treating demential syndromes comprises administering a therapeutically effective amount of gammahydroxybutyric acid (or pharmaceutically acceptable salt).
IT97MI001613A 1997-07-07 1997-07-07 Treating demential syndromes comprising administration of gammahydroxybutyric acid IT1293583B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT97MI001613A IT1293583B1 (en) 1997-07-07 1997-07-07 Treating demential syndromes comprising administration of gammahydroxybutyric acid
CA 2217902 CA2217902A1 (en) 1997-07-07 1997-10-08 Use of gammahydroxybutyrric acid for the treatment of demential syndromes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001613A IT1293583B1 (en) 1997-07-07 1997-07-07 Treating demential syndromes comprising administration of gammahydroxybutyric acid

Publications (3)

Publication Number Publication Date
ITMI971613A0 ITMI971613A0 (en) 1997-07-07
ITMI971613A1 ITMI971613A1 (en) 1999-01-07
IT1293583B1 true IT1293583B1 (en) 1999-03-08

Family

ID=11377515

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001613A IT1293583B1 (en) 1997-07-07 1997-07-07 Treating demential syndromes comprising administration of gammahydroxybutyric acid

Country Status (2)

Country Link
CA (1) CA2217902A1 (en)
IT (1) IT1293583B1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013024028A1 (en) * 2011-08-12 2013-02-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compounds and compositions for treating proteinopathies
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (en) 2016-07-22 2017-11-30 Flamel Ireland Ltd FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
CA3127871A1 (en) 2019-03-01 2020-09-10 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Also Published As

Publication number Publication date
CA2217902A1 (en) 1999-01-07
ITMI971613A0 (en) 1997-07-07
ITMI971613A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
FI946173A0 (en) A method for improving the efficacy of drug delivery using modified saponins
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
ZA977783B (en) Method of inhibiting fibrosis with a somatostatin agonist
EP1033998A4 (en) Method of suppressing beta-amyloid-related changes in alzheimer's disease
GB2303064B (en) Medicament for nasal administration
EP1086702A3 (en) Method for reduction of headache pain
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
HK1018012A1 (en) Inhaler for administering medicaments from blisterpacks
EP1555025A3 (en) Use of dehydroepiandrosterone analogs for the treatment of asthma
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
HK1034446A1 (en) Therapeutic agents.
IT1293583B1 (en) Treating demential syndromes comprising administration of gammahydroxybutyric acid
AU3046897A (en) Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
SE9703929D0 (en) Therapeutic use and method
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
EP0689839A3 (en) Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide
HK1028545A1 (en) Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms
IL146962A0 (en) Aminotetralin derivatives for the therapy of cardiovascular diseases
ZA96260B (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
EP0872239A3 (en) Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia
CA2237643A1 (en) Therapeutic agent for acute hepatic failure
WO2000010544A3 (en) A method for preventing the onset of asthma

Legal Events

Date Code Title Description
0001 Granted